Allen & Overy advises Rexam on sale of its healthcare business
Allen & Overy has advised Rexam, a global beverage can maker, on the sale of the bulk of its healthcare business to Montagu Private Equity for $805m (£494m).
In this transaction, Rexam is selling its pharmaceutical devices and prescription retail packaging divisions, returning £450m in cash to shareholders.
The transaction is subject to consultation with various European works councils, is conditional on the necessary regulatory approvals and is subject to certain adjustments at completion. The transaction is expected to complete around the middle of 2014.
News from Allen & Overy
News from The Lawyer
Briefings from Allen & Overy
This year is expected to be a bumper year for pension risk transfer in the UK.
The OFAC has imposed a new set of ‘sectoral sanctions’ against two Russian energy firms and two Russian banks pursuant to Executive Order 13662.
Analysis from The Lawyer
At the time of its launch Accutrainee was described as a revolutionary change to the training model. Has it proved to be so? Not really.
Shearman & Sterling is making its presence felt in the City, squaring up to magic circle firms and looking to muscle in on key relationships. Private equity house Bridgepoint is one outfit that has had its head turned by the US firm.